Similar Papers

Paper Title
Journal
Date
Author
Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing Phase I/II Clinical Study
Ewelina Mamcarz ...
Blood | VOL. 134
Ewelina Mamcarz, et. al.Ewelina Mamcarz ...
13 Nov 2019
Malignancy in disguise: ALK-positive anaplastic large cell lymphoma with refractory hyperinflammation and CNS involvement.
Zhongbo Hu ... Gabriela Gheorghe
Pediatric blood & cancer | VOL. 70
Zhongbo Hu, et. al.Zhongbo Hu ... Gabriela Gheorghe
17 May 2023
Retroperitoneal paraganglioma.
Raymond Barfield ... Fredric A Hoffer
Medical and pediatric oncology | VOL. 39
Raymond Barfield, et. al.Raymond Barfield ... Fredric A Hoffer
20 Jun 2002
Novel case of ELANE-related severe congenital neutropenia with initially normal bone marrow.
Camille Keenan ... Rohith Jesudas
Pediatric blood & cancer | VOL. 70
Camille Keenan, et. al.Camille Keenan ... Rohith Jesudas
08 Jun 2023
View more papers

More From: Hepatology

Paper Title
Journal
Date
Author
Unveiling the immune landscape of IDH1-mutant cholangiocarcinoma: Pathways to new therapies
Binbin Li ... Sumera I Ilyas
Hepatology | VOL. -
Binbin Li, et. al.Binbin Li ... Sumera I Ilyas
21 Jan 2025
Interpreting the 100% disease control rate of Sin-Bev-RT in HCC with PVTT
Tongtong Pan ... Lihuang Su
Hepatology | VOL. -
Tongtong Pan, et. al.Tongtong Pan ... Lihuang Su
13 Jan 2025
Erratum: Expression and functional significance of Twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry
-
Hepatology | VOL. -
--
20 Nov 2024
Mitochondrial genome diversity drives heterogeneity in hepatocellular carcinoma
Tatsuhiro Shibata ... Yujin Hoshida
Hepatology | VOL. -
Tatsuhiro Shibata, et. al.Tatsuhiro Shibata ... Yujin Hoshida
12 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.